These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38908207)

  • 1. Advances in precision gene editing for liver fibrosis: From technology to therapeutic applications.
    Ji P; Li Y; Wang Z; Jia S; Jiang X; Chen H; Wang Q
    Biomed Pharmacother; 2024 Aug; 177():117003. PubMed ID: 38908207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects.
    Singh K; Bhushan B; Kumar S; Singh S; Macadangdang RR; Pandey E; Varma AK; Kumar S
    Curr Gene Ther; 2024; 24(5):377-394. PubMed ID: 38258771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
    Raikwar SP; Kikkeri NS; Sakuru R; Saeed D; Zahoor H; Premkumar K; Mentor S; Thangavel R; Dubova I; Ahmed ME; Selvakumar GP; Kempuraj D; Zaheer S; Iyer SS; Zaheer A
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):608-641. PubMed ID: 31011884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
    Carpenter JC; Lignani G
    Neurotherapeutics; 2021 Jul; 18(3):1515-1523. PubMed ID: 34235638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
    Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
    Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.
    Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK
    AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies.
    Singh D
    AAPS PharmSciTech; 2024 Jun; 25(5):129. PubMed ID: 38844700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing.
    Iqbal Z; Rehman K; Xia J; Shabbir M; Zaman M; Liang Y; Duan L
    Biomater Sci; 2023 May; 11(11):3762-3783. PubMed ID: 37102700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases.
    Walsh C; Jin S
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Advancements for Human Health.
    Davis DJ; Yeddula SGR
    Mo Med; 2024; 121(2):170-176. PubMed ID: 38694604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical applications of clustered regularly interspaced short palindromic repeats (CRISPR/Cas) tool: A comprehensive overview.
    Araldi RP; Khalil C; Grignet PH; Teixeira MR; de Melo TC; Módolo DG; Fernandes LGV; Ruiz J; de Souza EB
    Gene; 2020 Jun; 745():144636. PubMed ID: 32244056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas13a system: a novel approach to precision oncology.
    Zhang J; You Y
    Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic Genome Editing and its Potential Enhancement through CRISPR Guide RNA and Cas9 Modifications.
    Batzir NA; Tovin A; Hendel A
    Pediatr Endocrinol Rev; 2017 Jun; 14(4):353-363. PubMed ID: 28613045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.
    Kong H; Ju E; Yi K; Xu W; Lao YH; Cheng D; Zhang Q; Tao Y; Li M; Ding J
    Adv Sci (Weinh); 2021 Dec; 8(24):e2102051. PubMed ID: 34665528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.